Functions of CD40 and its Ligand, gp39 (CD40L)

被引:143
|
作者
Laman, JD
Claassen, E
Noelle, RJ
机构
[1] DARTMOUTH COLL SCH MED,DEPT MICROBIOL,LEBANON,NH 03756
[2] TNO PREVENT & HLTH,DIV INFECT DIS & IMMUNOL,2301 CE LEIDEN,NETHERLANDS
关键词
CD40; Ligand; gp39; lymphocyte activation; signal transduction; tolerance; cognate T and B cell interaction; antibody; isotype switching; autoimmunity; immunotherapy;
D O I
10.1615/CritRevImmunol.v16.i1.40
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Initially, a role for the interaction between CD40, expressed on B cells, and gp39 (CD40L), expressed on activated T cells, has been defined in humoral immunity. CD40-CD40L interaction is an essential signal for B cell proliferation, expression of activation markers, immunoglobulin production, and isotype switching. CD40-CD40L interaction is also required for formation of B memory cells and germinal centers, and signaling through CD40 prevents apoptosis of germinal center B cells. Defective expression of CD40L in humans leads to an inability to produce isotypes other than IgM (hyper IgM syndrome), and to an absence of germinal centers. More recent evidence indicates an expansion of the role of the CD40-CD40L axis in cellular interactions beyond antibody formation. Induced expression of CD40 on monocytes can lead to CD40L-activated monocyte effector mechanisms. In addition, CD40-CD40L interactions are crucially involved in development of autoimmune disease in a number of animal models. CD40-CD40L interactions also impact on growth regulation of certain carcinomas. Manipulation of CD40L has also been used to develop novel strategies for long-term antigen-specific tolerization of peripheral T cells. Finally, the CD40-CD40L axis is involved in thymic selection. Following is a comprehensive overview of CD40L-CD40 interactions in physiological and pathogenic cellular responses and a discussion of the therapeutic ramifications of these interactions.
引用
收藏
页码:59 / 108
页数:50
相关论文
共 50 条
  • [41] The Role Of CD40L And CD40 In The Pathogenesis Of Kawasaki Disease
    Parsaud, Leon
    Arjmand, Parnian
    Duong, Trang T.
    Yeung, Rae S.
    CIRCULATION, 2015, 131
  • [42] The CD40/CD40L axis in glioma progression and therapy
    Walker, Paul R.
    Migliorini, Denis
    NEURO-ONCOLOGY, 2015, 17 (11) : 1428 - 1430
  • [43] CD40/CD40L and cardiovascular risk in patients on haemodialysis: a role for soluble CD40? Reply
    Desideri, Giovambattista
    Panichi, Vincenzo
    Ghiadoni, Lorenzo
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2011, 26 (07) : 2415 - 2416
  • [44] Increased stability of CD40 ligand (CD40L) mRNA in SLE T cells.
    Kirou, KA
    Garofalo, G
    Kim, SJ
    George, SY
    Crow, MK
    Kirkland, M
    ARTHRITIS AND RHEUMATISM, 2002, 46 (09): : S486 - S486
  • [45] Integrin Binding to the Trimeric Interface of CD40L Plays a Critical Role in CD40/CD40L Signaling
    Takada, Yoko K.
    Yu, Jessica
    Shimoda, Michiko
    Takada, Yoshikazu
    JOURNAL OF IMMUNOLOGY, 2019, 203 (05): : 1383 - 1391
  • [46] In Vivo and In Vitro Characterization of Domain Antibodies (dAbs) Targeting CD40 Ligand (CD40L)
    Xie, J.
    Borowski, V.
    Susulic, V.
    Wang, X.
    Rex-Rabe, S.
    Kuhn, R.
    Carroll, K.
    Brosius, R.
    Ignatovich, O.
    Drew, P.
    Grant, S.
    Tamura, J.
    Bryson, J.
    Salter-Cid, L.
    Suchard, S.
    Nadler, S.
    Suri, A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 : 532 - 532
  • [47] CD40 ligand (CD40L) does not stimulate proliferation of vascular smooth muscle cells
    Hermann, A
    Schrör, K
    Weber, AA
    EUROPEAN JOURNAL OF CELL BIOLOGY, 2002, 81 (04) : 213 - 221
  • [48] CD40 LIGAND CD40 DEFICIENCY
    CASTIGLI, E
    FULEIHAN, R
    RAMESH, N
    TSITSIKOV, E
    TSYTSYKOVA, A
    GEHA, RS
    INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 1995, 107 (1-3) : 37 - 39
  • [49] In Vivo and In Vitro Characterization of Domain Antibodies (dAbs) Targeting CD40 Ligand (CD40L)
    Suri, A.
    Tamura, J.
    Xie, J.
    Price, L.
    Ignatovitch, O.
    Drew, P.
    Grant, S.
    Suchard, S.
    Heifets, M.
    Nadler, S.
    TRANSPLANTATION, 2012, 94 (10) : 461 - 461
  • [50] Platelet CD40 ligand (CD40L) -: subcellular localization, regulation of expression, and inhibition by clopidogrel
    Hermann, A
    Rauch, BH
    Braun, M
    Schrör, K
    Weber, AA
    PLATELETS, 2001, 12 (02) : 74 - 82